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The objective of this study was to investigate the hemocompatibility and cell responses to some novel poly(L-lactide) (PLA) 
composites containing surface modified hydroxyapatite particles for potential applications as a bone substitute material. The 
surface of hydroxyapatite (HA) particles was first grafted with L-lactic acid oligomers to form grafted HA (g-HA) particles. 
The g-HA particles were further blended with PLA to prepare g-HA/PLA composites. Our previous study has shown signifi-
cant improvement in tensile properties of these materials due to the enhanced interfacial adhesion between the polymer matrix 
and HA particles. To further investigate the potential applications of these composites in bone repair and other orthopedic sur-
geries, a series of in vitro and in vivo experiments were conducted to examine the cell responses and hemocompatibility of the 
materials. In vitro experiments showed that the g-HA/PLA composites were well tolerated by the L-929 cells. Hemolysis of the 
composites was lower than that of pure PLA. Subcutaneous implantation demonstrated that the g-HA/PLA composites were 
more favorable than the control materials for soft tissue responses. The results suggested that the g-HA/PLA composites are 
promising and safe materials with potential applications in tissue engineering. 
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Hydroxyapatite (HA) is one of the most important ceramics 
in clinical applications because of its similarity to bone 
minerals in both structure and composition and excellent 
bioactivity and osteoconductivity [1]. However, its brittle-
ness and low mechanical strength limits its applications in 
load bearing implants. A number of HA/polymer compos-
ites have attracted much attention to offset HA mechanical 
weakness [2,3]. Among them, poly(L-lactide) (PLA) is 
commonly used as a matrix material in constructing biode-
gradable composites for bone repairing [4,5]. 
As filler, however, HA does not strongly adhere to the 
PLA matrix. This weak adhesion is due to the significant 
chemical dissimilarity between HA and PLA. The weak 
interfacial layer between the filler and the matrix can be 
readily destroyed after implantation; therefore, HA parti-
cles easily escape from the polymer matrix leading to a 
rapid decrease in mechanical strength. Improvement of the 
interfacial adhesion between the HA particles and the PLA 
matrix has become critical in preparing HA/PLA compos-
ites [6]. 
Recently, we reported a new and simple method for pre-
paring L-lactic acid oligomer grafted HA (g-HA)/PLA 
composites [7]. Compared to ordinary HA/PLA compos-
ites [8,9], the tensile strength and modulus were effectively 
improved. The g-HA particles demonstrated improved ad-
hesion with PLA matrix, and the g-HA/PLA composites 
showed greater enhancement of tensile strength and elastic 
modulus in comparison with non-modified HA/PLA com-
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posites [7]. We intend to further assess these materials for 
possible bone repair and clinical applications. 
In this work, the in vitro cytotoxicity and in vivo bio-
compatibility of g-HA/PLA composites were investigated. 
The cytotoxicity of the g-HA/PLA composites was investi-
gated using L929 cells as model cells. The blood compati-
bility was evaluated by a hemolysis test. Histological 
evaluation of the materials after subcutaneous implantation, 
up to eight weeks in rabbits, was reported. 
1  Materials and methods 
1.1  Preparation of g-HA/PLA composite rods 
The g-HA particles were prepared as described in our pre-
vious work [7]. The method for the preparation of g-HA is  
briefly depicted in Figure 1. To HA particles that were uni-
formly dispersed in tetrahydrofuran, L-lactic acid was added 
dropwise. After the toluene was added, the mixture was 
preserved at 85°C for 6–8 h. After washing with ethyl ace-
tate, the particles were polymerized with L-lactide at 130°C 
for 24 h with stannous octoate as a catalyst. The product 
was suspended in chloroform and separated by centrifuga-
tion. They were further washed with excessive chloroform 
and vacuum-dried yielding L-lactic acid oligomer grafted 
HA, g-HA.  
The g-HA particles and PLA were placed in a mould (10 
cm×8 cm×1.1 cm) and pressed to make slices under 6.0 
MPa of pressure at 160°C for 20 min. Then the slices were 
cut and shaped into rods with a diameter of 2.5 mm and 





Figure 1  Schematic illustration for the preparation of g-HA particles. 
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1.2  Scanning electron microscopy observations 
A scanning electron microscope (SEM; FEI Sirion 200, 
Philips) was used to observe the morphology of the frac-
tured surface of the composites. A layer of gold was plated 
uniformly over the fractured surfaces before examination. 
1.3  In vitro cell responses 
Murine fibroblast cells (L-929) were used to examine the 
cell responses to g-HA/PLA composites. L-929 cells were 
cultured in Dulbecco’s modified Eagle’s medium (DMEM), 
10% fetal bovine serum (FBS), 100 U mL−1 penicillin and 
100 μg mL−1 streptomycin at 37°C in a humidified atmos-
phere of 5% CO2. The tests were carried out by indirect 
contact. 
Extracts were prepared using DMEM serum free medium 
as the extraction medium. The samples were immersed into 
DMEM at a ratio of 1.25 mL cm−2 (medium/sample) in a 
humidified atmosphere with 5% CO2 at 37°C for 72 h ac-
cording to the International Organization for Standardiza-
tion (ISO 10993-5:1999 [10] and ISO 10993-12:1996 [11]), 
then filtered with a 0.22 μm sterile membrane. All extracts 
were used within 24 h. DMEM medium was used as a nega-
tive control and DMEM medium with 10% dimethylsulfox-
ide (DMSO) was a positive control. Cells were seeded into 
96-well plates at a density of 5×103 cells/well and incubated 
for 24 h at 37°C to allow attachment. The culture medium 
was removed and 100 μL extract was added to the wells. 
After incubating the cells in a humidified atmosphere with 
5% CO2 at 37°C for 1, 2 and 3 d, the 96-well plates were 
observed under an optical microscope. After this, 10 μL 
sterile MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-      
zolium bromide) was added to each well. The samples were 
incubated with MTT for 4 h at 37°C, then 100 μL of for-
mazan solution was added, followed by incubation over-
night. The absorbance of the samples at 570 nm was meas-
ured with an Elx-800 spectrophotometer (bio-Tek instru-
ments). 
1.4  Statistical analysis 
Cell culture experiments were performed at least three times. 
All the data collected throughout the study were expressed 
as mean±SD. Experimental data were analyzed using Mi-
crosoft Excel software. The statistical significance was 
evaluated by a Student’s t-test. A P-value less than 0.05 was 
considered statistically significant. 
1.5  Hemolysis tests 
Healthy New Zealand white rabbit blood containing potas-
sium oxalate (1.0 mg mL−1) was taken and diluted with 
normal saline (4:5 ratio by volume). Specimens of ap-
proximately 0.5 g (30 mm×8 mm×1 mm) were dipped into a 
standard tube containing 10 mL of normal saline that was 
previously incubated at 37°C for 30 min. Then 0.2 mL of 
diluted blood was added to this standard tube and the mix-
tures incubated for 60 min at 37°C. A normal saline solution 
was used as a negative control and distilled water as a posi-
tive control. After incubation, samples were centrifuged for 
5 min. The supernatant was removed and transferred to a 
cuvette for spectroscopic analysis at 545 nm. The hemolysis 
was calculated using an ultraviolet spectrophotometer (721; 
Huichuang Instrument Co., Ltd., China). The hemolysis 
value was calculated based on the average of five replicates: 
 (test)  (negative control)
Hemolysis







1.6  In vivo implantation 
The 5 wt% g-HA/PLA composite and PLA rods were rinsed 
with 70% ethanol three times, followed by three washes 
with phosphate-buffered solution (PBS) and dried in a ster-
ilized hood prior to the implantation. 
A total of 18 New Zealand white rabbits weighing be-
tween 2.5 and 3.5 kg were used for in vivo implantation of 
the composite rods. The rabbits were anesthetized by an 
intravenous injection of Nembutal (30 mg kg−1). The opera-
tions were performed under standard aseptic conditions. 
After four 1.5 cm incisions were made in the shaved skin 
of each rabbit’s dorsum, four subcutaneous pockets were 
created bluntly. A rod sample, either pure PLA or 5 wt% 
g-HA/PLA composite was inserted in each of the pockets 
(Figure 2A) and the skin then sutured. Following all surgi-
cal procedures, the rabbits were kept in cages and main-
tained on a regular laboratory diet. The rabbits were sacri-
ficed by Nembutal overdose at each of the follow-up inter-
vals which included one, four and eight weeks post-implan-      
tation. Tissue surrounding the implanted rod (within 5 mm) 
was retrieved for histological examination (Figure 2B–D). 
1.7  Histological examination 
Retrieved specimens were fixed in 10% (v/v) buffered for-
malin, dehydrated in a graded series of ethanol, and em-
bedded in paraffin. The tissue blocks were then stained with 
hematoxylin and eosin (H&E) for observing the nucleus and 
cytoplasm. 
2  Results and discussion 
2.1  SEM observations 
The SEM images of the fractured surface of 5 wt% HA/PLA 
and 5 wt% g-HA/PLA composite are shown in Figure 3. It 
indicates that g-HA particles have a more uniform distribu- 
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Figure 2  Implantation of g-HA/PLA composite rods. A, The composite 
rod was implanted in a subcutaneous pocket. B, An intraoperative view on 
the subcutaneously implanted composite rod at eight weeks which could be 
retrieved easily. C, The explanted composite rod at eight weeks which 
maintained its original dimension and volume. D, The tissue surrounding  
the composite rod at eight weeks post-implantation. 
 
Figure 3  SEM observation of the surface morphologies of 5 wt% 
HA/PLA (A) and 5 wt% g-HA/PLA composite (B). 
tion with few agglomerates when compared with the HA par-
ticles. 
2.2  In vitro cell responses of the g-HA/PLA composites 
Figure 4 shows the viability of the L-929 murine fibroblast 
cells expressed as a percentage of the viability of cells cul-
tured in the negative control following culture in pure PLA 
and g-HA composite extraction medium at days 1, 2 and 3. 
Although there was a slight decrease in cell viability in both 
PLA and g-HA/PLA extracts in comparison to the negative 
control, there was no significant difference in cell responses 
between the PLA and g-HA/PLA composite. While the cell 
viability in PLA was 89.1%–98.6%, in g-HA/PLA it was 
about 90.8%–97.0%. This indicated that the surface modi-
fied g-HA/PLA materials can facilitate cell migration and 
attachment onto the material surfaces as well as PLA. The 
results also indicated that the composites were not toxic to 
the cells. 
Figure 5 demonstrates the morphologies of L-929 cells 
cultured in the control samples, and the extracts of PLA and 
g-HA/PLA composites after a 3-d incubation. Healthy 
morphology of cells with a flattened spindle shape was 
demonstrated in PLA, g-HA/PLA composites and the nega-
tive control samples (Figure 5A–E). An abundant growth of 
cells was observed on the negative control sample (Figure 
5A) as well as on the composites (Figure 5C–E). Cell pro-
liferation was limited to PLA (Figure 5B) and suppressed 
by the toxic substrate in the positive control (Figure 4F). 
Both the MTT and optical microscopic observation indi-
cated that the g-HA/PLA composites can be well tolerated 
by L-929 cells. 
2.3  Hemocompatibility of g-HA/PLA composites 
Figure 6 shows the hemolysis of pure PLA and g-HA/PLA  
 
 
Figure 4  Cell viability expressed as percentage of viable cells in the 
control after 1, 2 and 3 d in culture with extraction medium containing pure  
PLA and g-HA/PLA composites. 
 
Figure 5  Optical micrographs of L-929 cells that were cultured as a nega-
tive control (A), with PLA (B), with 5 wt% g-HA/PLA (C), 10 wt%  
g-HA/PLA (D), 20 wt% g-HA/PLA (E), and the positive control for 3 d (F). 
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Figure 6  Percent hemolysis of pure PLA and g-HA/PLA composites. 
composites. In comparison with pure PLA, there is a decrease 
in hemolysis values in all composite materials. With an in-
crease in g-HA content in the composite materials from 5 
wt% to 10 wt% and 20 wt%, the hemolysis of the composites 
decreased from 2.05% to 1.87% and 1.66%. The results indi-
cated good hemocompatibility of g-HA, and the addition of 
g-HA particles had not deteriorated the biocompatibility of 
the matrix PLA. Moreover, the hemolysis of pure PLA and 
g-HA/PLA composites was both lower than 5%. 
2.4  In vivo studies of the composites 
In vivo studies indicated that the volume of the rod sample  
at eight weeks post-implantation was well maintained with a 
diameter of 2.5 mm, as originally fabricated (Figure 2C). 
The histological examination results (Figure 7A and B) re-
vealed that the fibrous tissues around PLA and the 5 wt% 
g-HA/PLA composite denaturalized and the structures of 
fibrous tissue layer could not be distinctly observed after 
one week. There were many inflammatory cells, such as 
lymphocytes, neutrophils or macrophages between the fi-
brous tissue layers. Substances like fibrin exuded from the 
inflammatory regions. The evident early post operation in-
flammation was induced by the injured muscle fibers due to 
the surgical procedure of implantation. The inflammatory 
cells observed at this stage disappeared four weeks after 
implantation (Figure 7C and D). Therefore, it was reason-
able to conclude that inflammation could be attributed to the 
injury caused by the implantation procedure. 
At four weeks post-implantation, the structures of fibrous 
tissue around PLA and the 5 wt% g-HA/PLA composite 
were both distinct and arranged regularly. The neutrophils 
and macrophages could not be observed and few lympho-
cytes were seen between the fibrous tissues. Compared with 
the implantations at one week, the inflammatory reaction 
was obviously weaker. At eight weeks post-implantation, 
there were no inflammatory cells in the tissue around the 
g-HA/PLA composite (Figure 7E and F). A fibrous tissue 
layer could be observed with evenly distributed fibrocytes 
and collagen fibers. In the structure of the fibrous tissue, 
there were no distinct differences between 4 and 8 weeks 
post-implantation. 
There were no significant differences in soft tissue re-
sponse to the various materials when implanted subcutane-
ously (Figure 7A–F), which confirms that the PLA and  
 
 
Figure 7  Representative histological sections of the tissues surrounding the rods implanted subcutaneously. A, PLA after one week implantation. B, 5 wt% 
g-HA/PLA, one week after implantation. C, PLA four weeks after implantation. D, 5 wt% g-HA/PLA at four weeks post-implantation. E, PLA at eight 
weeks post-implantation. F, 5 wt% g-HA/PLA eight weeks after implantation. Images presented are at 20× magnification. ly, lymphocytes; mac, macro- 
phages; neu, neutrophils. 
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g-HA/PLA composite do not differ in their in vivo biocom-
patibility when implanted ectopically. Histologically, nei-
ther macrophages nor inflammatory giant cells were seen 
after eight weeks, indicating that g-HA/PLA composites are 
biocompatible and induced no tissue reactions within the 
experimental period. 
3  Conclusion 
This study investigated the cytotoxicity, hemocompatibility 
and the inflammatory effect of g-HA/PLA materials. The 
results indicate that the g-HA/PLA composites are not toxic 
to cells and the g-HA particles with good hemocompatibil-
ity do not deteriorate the biocompatibility of the matrix 
PLA. Histological examination of the composite materials 
up to eight weeks after subcutaneous implantation demon-
strated that no inflammation was induced by the materials, 
indicating a good biocompatibility of the g-HA/PLA com-
posites. Although further studies on long-term degradation 
of these materials are needed, the results obtained from the 
current study are encouraging for clinical usage in various 
applications. 
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